Kabra Drugs Limited (BOM:524322)
India flag India · Delayed Price · Currency is INR
25.43
-0.67 (-2.57%)
At close: Jun 17, 2026

Kabra Drugs Balance Sheet

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
105.82212.9926.710.030.01
Short-Term Investments
0.440.440.44--
Cash & Short-Term Investments
106.26213.4327.150.030.01
Cash Growth
-50.21%686.23%91932.82%133.67%-87.10%
Accounts Receivable
707.766.016.0166
Receivables
707.766.016.016.446.72
Other Current Assets
25.2232.1912.330.330.33
Total Current Assets
839.23251.6245.486.87.06
Property, Plant & Equipment
8.350.44---
Other Intangible Assets
0.07----
Other Long-Term Assets
0.330.230.230.230.23
Total Assets
862.71252.2945.727.047.3
Accounts Payable
548.35----
Short-Term Debt
4.294.3717.0913.8210.26
Current Portion of Leases
0.3----
Current Income Taxes Payable
5.08----
Other Current Liabilities
7.391.3717.80.530.97
Total Current Liabilities
565.45.7434.8914.3511.23
Long-Term Leases
1.1----
Long-Term Deferred Tax Liabilities
0.060.01---
Other Long-Term Liabilities
---000
Total Liabilities
566.565.7434.8914.3511.23
Common Stock
237.08237.0843.8943.8943.89
Retained Earnings
59.079.47-58.56-51.2-47.82
Comprehensive Income & Other
-0-025.5--
Shareholders' Equity
296.14246.5510.83-7.31-3.93
Total Liabilities & Equity
862.71252.2945.727.047.3
Total Debt
5.694.3717.0913.8210.26
Net Cash (Debt)
100.57209.0610.06-13.79-10.25
Net Cash Growth
-51.89%1977.87%---
Net Cash Per Share
4.2419.132.29-3.14-2.33
Filing Date Shares Outstanding
23.6323.714.394.394.39
Total Common Shares Outstanding
23.6323.714.394.394.39
Working Capital
273.84245.8810.6-7.54-4.16
Book Value Per Share
12.5310.402.47-1.67-0.90
Tangible Book Value
296.08246.5510.83-7.31-3.93
Tangible Book Value Per Share
12.5310.402.47-1.67-0.90
Machinery
-0.44-1.661.66